Study title: E-BRO-AWB 1 (Nov. 2005 - Mar. 2006): not-randomized, open post-marketing surveillance study
| Type of medicine: Herbal and homoeopathic medicines | |||||
| Therapeutic area: Respiratory Tract Diseases [C08] | |||||
| Brands: Please see report | |||||
| MAH holders: Please see report | |||||
| Assessment: | |||||
| Active substance: liquid thyme extract (extracting ratio: 1 : 2 - 2.5, extracting agents: ammonia solution 10% [m/m] : glycerol 85% [m/m]: ethanol 90 % [V/V] : water (1:20:70:109)) liquid Ivy leaf extract (extracting ratio: 1:1, extracting agent: ethanol 70 % [V/V]) | |||||
| ATC code: R05CA10 | |||||
| Document link: | |||||
| Document date: | |||||
| Study number: | |||||
| EudraCT number: | |||||
| Scope of study: CLINICAL | |||||
| Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
| - | - | - | - | - | |